Tag Archives: array biopharma

June, 2018

December, 2017

  • 20 December

    Array BioPharma and Pfizer Collaborate on Novel Anti-Cancer Combinations

    BOULDER, Colo., Dec. 19, 2017 /PRNewswire/ — Array BioPharma (Nasdaq: ARRY) announced today that it has entered into a clinical trial collaboration agreement with Pfizer to investigate the safety and efficacy of several novel anti-cancer combinations, including Array’s MEK inhibitor, binimetinib, with Pfizer’s investigational PARP inhibitor talazoparib, and avelumab*, a …

September, 2017

July, 2017

May, 2017

March, 2017

November, 2016

April, 2016

December, 2015

  • 16 December

    Array Biopharma’s Melanoma Drug Succeeds in Late-Stage Study

    BOULDER, Colo., Dec. 16, 2015 /PRNewswire/ — Array BioPharma (ARRY) today reported top-line results from the ongoing Phase 3 clinical trial of binimetinib in patients with advanced NRAS-mutant melanoma, known as the NEMO trial.  The study met its primary endpoint of improving progression-free survival (PFS) compared with dacarbazine treatment. The median …